1-20 of 26
Asif Alavi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Initial Results from the BEACON Clinical Study: A Phase 1/2 Study Evaluating the Safety and Efficacy of a Single Dose of Autologous CD34+ Base Edited Hematopoietic Stem Cells (BEAM-101) in Patients with Sickle Cell Disease with Severe Vaso-Occlusive Crises

Ashish O. Gupta, Akshay Sharma, Haydar Frangoul, Jignesh Dalal, Julie Kanter, Asif Alavi, John DiPersio, Mary Eapen, Jennifer J. Jaroscak, Ernesto Ayala, Edward D. Ziga, Stacey Rifkin-Zenenberg, Alex C. Minella, Guo Chen, Yinzhong Chen, Priya S. Chockalingam, Ling Lin, Marcelyne Joseney-Antoine, Leanne Ianniello, Beth Gardner, Adam J. Hartigan, Giuseppe Ciaramella, Sunita Goyal, Amy Simon, Alexis Thompson, Matthew M. Heeney
Journal: Blood
Blood (2024) 144 (Supplement 1): 513.
https://doi.org/10.1182/blood-2024-204888
Published: 2024
Journal Articles

Does Choice of Salvage Regimen Impact Stem Cell Mobilization in Hodgkin's Lymphoma?

Abdul Moiz Khan, Neha Venkatesh, Joseph P. Uberti, Voravit Ratanatharathorn, Dipenkumar Modi, Lois Ayash, Asif Alavi, Andrew Kin, Aasiya Matin, Abhinav Deol
Journal: Blood
Blood (2022) 140 (Supplement 1): 7565–7566.
https://doi.org/10.1182/blood-2022-164618
Published: 2022
Journal Articles

HLA-Haploidentical Vs Mismatched Unrelated Donor Transplants with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis for AML and MDS: Is There a Winner?

Dipenkumar Modi, Maya Shatta, Seongho Kim, Abhinav Deol, Andrew Kin, Asif Alavi, Lois Ayash, Voravit Ratanatharathorn, Joseph P. Uberti
Journal: Blood
Blood (2022) 140 (Supplement 1): 694–695.
https://doi.org/10.1182/blood-2022-166536
Published: 2022
Journal Articles

National Burden of Encapsulated Bacterial Infections in Sickle Cell Disease

Aditi Sharma, Asif Alavi, Indryas L. Woldie, Vijendra Singh
Journal: Blood
Blood (2022) 140 (Supplement 1): 5148–5149.
https://doi.org/10.1182/blood-2022-167224
Published: 2022
Journal Articles

Interim Safety and Efficacy Results from a Phase 1/2 Study of Zinc Finger Nuclease-Modified Autologous Hematopoietic Stem Cells for Sickle Cell Disease (PRECIZN-1)

Asif Alavi, Mehrdad Abedi, Suhag Parikh, Richard Boismenu, Michael Chen, Ben L. Hsu, Bettina M. Cockroft, Isobelle Galeon, Pablo Rendo, Mark C. Walters
Journal: Blood
Blood (2022) 140 (Supplement 1): 4907–4909.
https://doi.org/10.1182/blood-2022-163725
Published: 2022
Journal Articles

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study

Clinical Trials & Observations
Corey Cutler, Stephanie J. Lee, Sally Arai, Marcello Rotta, Behyar Zoghi, Aleksandr Lazaryan, Aravind Ramakrishnan, Zachariah DeFilipp, Amandeep Salhotra, Wanxing Chai-Ho, Rohtesh Mehta, Trent Wang, Mukta Arora, Iskra Pusic, Ayman Saad, Nirav N. Shah, Sunil Abhyankar, Carlos Bachier, John Galvin, Annie Im, Amelia Langston, Jane Liesveld, Mark Juckett, Aaron Logan, Levanto Schachter, Asif Alavi, Dianna Howard, Harlan W. Waksal, John Ryan, David Eiznhamer, Sanjay K. Aggarwal, Jonathan Ieyoub, Olivier Schueller, Laurie Green, Zhongming Yang, Heidi Krenz, Madan Jagasia, Bruce R. Blazar, Steven Pavletic
Journal: Blood
Blood (2021) 138 (22): 2278–2289.
https://doi.org/10.1182/blood.2021012021
Published: 2021
Includes: Supplemental data
Journal Articles

Incidence, Risk Factors and Outcomes of Pancytopenia Following Chimeric Antigen Receptor (CAR)-T Cell Therapy in Relapsed Refractory Diffuse Large B Cell Lymphoma

Malini Surapaneni, Samer Alkassis, Seongho Kim, Abhinav Deol, Lois Ayash, Asif Alavi, Andrew Kin, Voravit Ratanatharathorn, Joseph P. Uberti, Dipenkumar Modi
Journal: Blood
Blood (2021) 138 (Supplement 1): 4812.
https://doi.org/10.1182/blood-2021-148961
Published: 2021
Journal Articles

Feasibility of Outpatient CAR T Cell Therapy: Experience of a Single Institution

Yusra F Shao, Dipenkumar Modi, Andrew Kin, Asif Alavi, Lois Ayash, Voravit Ratanatharathorn, Joseph P. Uberti, Abhinav Deol
Journal: Blood
Blood (2021) 138 (Supplement 1): 4828.
https://doi.org/10.1182/blood-2021-146283
Published: 2021
Journal Articles

Outcome of Severe Aplastic Anemia Post Allogenic Stem Cell Transplant with Mycophenolate and Calcineurin Inhibitor for Graft Versus Host Disease Prophylaxis

Omar Albanyan, Hyejeong Jang, Seongho Kim, Andrew Kin, Asif Alavi, Lois Ayash, Voravit Ratanatharathorn, Dipenkumar Modi, Joseph P. Uberti, Abhinav Deol
Journal: Blood
Blood (2021) 138 (Supplement 1): 4879.
https://doi.org/10.1182/blood-2021-144995
Published: 2021
Journal Articles

Preliminary Safety and Efficacy Results from Precizn-1: An Ongoing Phase 1/2 Study on Zinc Finger Nuclease-Modified Autologous CD34+ HSPCs for Sickle Cell Disease (SCD)

Asif Alavi, Lakshmanan Krishnamurti, Mehrdad Abedi, Isobelle Galeon, David Reiner, Sharon E Smith, Lin Wang, Anne Ramezi, Pablo Rendo, Mark C. Walters
Journal: Blood
Blood (2021) 138 (Supplement 1): 2930.
https://doi.org/10.1182/blood-2021-151650
Published: 2021
Journal Articles

Epidemiology and Predictors of Blood Transfusion in Hospitalizations for Sickle Cell Disease

Aditi Sharma, Vijendra Singh, Asif Alavi
Journal: Blood
Blood (2021) 138 (Supplement 1): 3103.
https://doi.org/10.1182/blood-2021-154528
Published: 2021
Journal Articles

Bridging the Gap in Access to Transplant for Underserved Minority Patients Using Mismatched Unrelated Donors and Post-Transplant Cyclophosphamide: A National Marrow Donor Program/be the Match (NMDP/BTM) Initiative

Bronwen E. Shaw, PhD MRCP, FRCPath, Antonio Jimenez-Jimenez, MD MS, Linda J. Burns, MD, Brent Logan, PhD, Farhad Khimani, MD, Brian C. Shaffer, MD, Nirav N. Shah, MD, Alisha Mussetter, BS, ACRP-CP, Xiao-Ying Tang, MPH, John M McCarty, MD, Asif Alavi, MD, Nosha Farhadfar, MD, Katarzyna Jamieson, MD, Nancy M. Hardy, MD, Hannah Choe, MD, Richard F. Ambinder, MD, Claudio Anasetti, MD, Miguel-Angel Perales, MD, Alan Howard, PhD, Krishna V Komanduri, MD, Leo Luznik, MD, Maxim Norkin, MD PhD, Joseph Pidala, MD, Voravit Ratanatharathorn, MD, Dennis L. Confer, MD, Steven M Devine, MD, Mary M. Horowitz, MD MS, Javier Bolanos-Meade, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 48–49.
https://doi.org/10.1182/blood-2020-137677
Published: 2020
Journal Articles

Impact of Pre-Transplant Induction Therapy on Outcomes of Patients Who Undergo Autologous Stem Cell Transplantation for Mantle Cell Lymphoma in First Complete Remission

Omar Albanyan, MD, Samer Alkassis, Seongho Kim, PhD, Andrew Kin, MD, Asif Alavi, MD, Lois Ayash, MD, Voravit Ratanatharathorn, MD, Dipenkumar Modi, MD, Joseph P. Uberti, MD, PhD, Abhinav Deol, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–20.
https://doi.org/10.1182/blood-2020-140079
Published: 2020
Journal Articles

Use of Thymoglobulin with Lower Dose of Busulfan Results in Less Acute Gvhd Following Unrelated Donor Allogeneic Stem Cell Transplantation for AML without Affecting Relapse-Free and Overall Survival

Dipenkumar Modi, MD, Vijendra Singh, MD, Seongho Kim, PhD, Abhinav Deol, MD, Asif Alavi, MD, Lois Ayash, MD, Andrew Kin, MD, Voravit Ratanatharathorn, MD, Joseph P. Uberti, MD, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4488.
https://doi.org/10.1182/blood-2019-125418
Published: 2019
Journal Articles

Absolute Lymphocyte Count (ALC) Less Than 100 Predicts Adverse Transplant Outcomes with Rabbit Thymoglobulin in Patients Undergoing Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation

Dipenkumar Modi, MD, Malini Surapaneni, MD, Seongho Kim, PhD, Lois Ayash, MD, Asif Alavi, MD, Andrew Kin, MD, Voravit Ratanatharathorn, MD, Joseph P. Uberti, MD, PhD, Abhinav Deol, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4527.
https://doi.org/10.1182/blood-2019-125437
Published: 2019
Journal Articles

Can Peri-Transplant Radiation Therapy Improve Outcomes of Autologous Stem Cell Transplant in Hodgkin Lymphoma?

Harsh Shah, DO, Paramveer Singh, MD, Jorgena Kosti, DO, Hyejeong Jang, Seongho Kim, PhD, Andrew Kin, MD, Asif Alavi, MD, Lois Ayash, MD, Voravit Ratanatharathorn, MD, Joseph P. Uberti, MD, PhD, Abhinav Deol, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5702.
https://doi.org/10.1182/blood-2019-124931
Published: 2019
Journal Articles

Maintenance Therapy after Second Autologous Stem Cell Transplant in Multiple Myeloma Improves Overall Survival

Dipenkumar Modi, MD, Seongho Kim, PhD, Jie Chi, MD, Lois Ayash, MD, Asif Alavi, MD, Andrew Kin, MD, Voravit Ratanatharathorn, MD, Joseph P. Uberti, MD, PhD, Abhinav Deol, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3311.
https://doi.org/10.1182/blood-2019-124838
Published: 2019
Journal Articles

Post-ASCT Outcomes in Multiple Myeloma Patients Who Underwent ASCT with G-CSF+Plerixafor Versus G-CSF Mobilized Graft

Harsh Shah, DO, Seongho Kim, PhD, Paramveer Singh, Asif Alavi, MD, Lois Ayash, MD, Voravit Ratanatharathorn, MD, Joseph P. Uberti, MD, PhD, Abhinav Deol, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3350.
https://doi.org/10.1182/blood-2018-99-113713
Published: 2018
Journal Articles

Does Use of Biosimilar G-CSF Change Plerixafor Utilization during Stem Cell Mobilization for Autologous Stem Cell Transplant?

Nadine Abdallah, MD, Seongho Kim, PhD, Asif Alavi, MD, Lois Ayash, MD, Voravit Ratanatharathorn, MD, Joseph P. Uberti, MD, PhD, Abhinav Deol, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4557.
https://doi.org/10.1182/blood-2018-99-118400
Published: 2018
Journal Articles

Long-Term Outcomes of Allogeneic Stem Cell Transplant in Peripheral T-Cell Lymphoma

Dipenkumar Modi, MD, Seongho Kim, PhD, Abhinav Deol, MD, Asif Alavi, MD, Lois Ayash, MD, Voravit Ratanatharathorn, MD, Joseph P. Uberti, MD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4672.
https://doi.org/10.1182/blood-2018-99-114288
Published: 2018